glp-1 inflammatory bowel disease Receptor Agonists in Obese Patients with Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use | Current Obesity Reports Engineered probiotic restores GLP-1 signaling

Some combination products, such as Xultophy, contain both a long-acting insulin and a GLP-1 in the same pen

Kaur K & Misra S, 2024

Methods Three databases were searched (PubMed, Embase, and Cochrane Central Register of Controlled Trials) for trials published until the half of September 2024

The effectiveness of a weight loss app depends on your commitment to making long-term lifestyle changes and finding an app that aligns with your needs and preferences

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models